Scientists uncovered how the protein Piezo1 translates physical activity into stronger bones, offering a path to exercise-mimicking therapies. Scientists from the Department of Medicine, School of ...

Although the first GLP-1 drug was approved by the US Food and Drug Administration (FDA) in the early 2000s, it wasn't until a few years ago that its use became mainstream. Originally crafted to help ...

With a pair of Phase III trial flops, Ultragenyx will explore cost reductions as analysts turn attention to an upcoming ...

For those suffering from primary bone cancer — which is cancer that originates in the bones — a promising new medication may be on the horizon. The drug, called CADD522, works by blocking a gene ...

Ultragenyx Pharmaceutical said on Monday that late-stage studies showed its drug for a type of genetic bone disease failed to ...

The Food and Drug Administration on Tuesday approved an osteoporosis drug that represents the first new treatment approach in nearly two decades — a strategy based on a rare gene mutation in people ...

A new drug reduced bone loss in mice on the International Space Station, without causing any negative side effects. When you purchase through links on our site, we may earn an affiliate commission.

A new study gives reassuring news about the safety of Fosamax and Reclast, bone-building drugs taken by millions of American women. ap file photo A new study gives reassuring news about the safety of ...

Dec. 11 -- THURSDAY, Dec. 10 (HealthDay News) -- Bone-building drugs used by tens of millions of women to fight osteoporosis also cut the risk of breast cancer, suggesting the drugs may play a dual ...

BUFFALO, N.Y. – Children taking psychostimulant drugs prescribed for psychiatric disorders including attention deficit hyperactivity disorder (ADHD) who experience a common childhood fracture take ...